Title: (1) Basis of Presentation
Accounting Policies: The accompanying schedule of expenditures of federal awards includes the federal grant activity of The
Queen’s Health Systems and its subsidiaries (QHS) and is presented on the accrual basis of accounting.
The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of
Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit
Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this
schedule may differ from amounts presented in, or used in preparation of, the basic consolidated financial
statements.
De Minimis Rate Used: N
Rate Explanation: For the Research and Development Cluster, QHS did not elect to use the 10% de minimis indirect cost rate
as discussed in the Uniform Guidance Section 200.414 as QHS has a negotiated rate with the United
States Department of Health and Human Services for the year ended June 30, 2022.
The accompanying schedule of expenditures of federal awards includes the federal grant activity of The
Queen’s Health Systems and its subsidiaries (QHS) and is presented on the accrual basis of accounting.
The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of
Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit
Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this
schedule may differ from amounts presented in, or used in preparation of, the basic consolidated financial
statements.
Title: (2) Indirect Cost Rate
Accounting Policies: The accompanying schedule of expenditures of federal awards includes the federal grant activity of The
Queen’s Health Systems and its subsidiaries (QHS) and is presented on the accrual basis of accounting.
The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of
Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit
Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this
schedule may differ from amounts presented in, or used in preparation of, the basic consolidated financial
statements.
De Minimis Rate Used: N
Rate Explanation: For the Research and Development Cluster, QHS did not elect to use the 10% de minimis indirect cost rate
as discussed in the Uniform Guidance Section 200.414 as QHS has a negotiated rate with the United
States Department of Health and Human Services for the year ended June 30, 2022.
For the Research and Development Cluster, QHS did not elect to use the 10% de minimis indirect cost rate
as discussed in the Uniform Guidance Section 200.414 as QHS has a negotiated rate with the United
States Department of Health and Human Services for the year ended June 30, 2022.
Title: (3) Personal Protective Equipment Receipts (Unaudited)
Accounting Policies: The accompanying schedule of expenditures of federal awards includes the federal grant activity of The
Queen’s Health Systems and its subsidiaries (QHS) and is presented on the accrual basis of accounting.
The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of
Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit
Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this
schedule may differ from amounts presented in, or used in preparation of, the basic consolidated financial
statements.
De Minimis Rate Used: N
Rate Explanation: For the Research and Development Cluster, QHS did not elect to use the 10% de minimis indirect cost rate
as discussed in the Uniform Guidance Section 200.414 as QHS has a negotiated rate with the United
States Department of Health and Human Services for the year ended June 30, 2022.
QHS has received personal protective equipment totaling $93,000 at fair value in response to the
COVID-19 pandemic for the year ended June 30, 2022.
Title: (4) Provider Relief Funds
Accounting Policies: The accompanying schedule of expenditures of federal awards includes the federal grant activity of The
Queen’s Health Systems and its subsidiaries (QHS) and is presented on the accrual basis of accounting.
The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of
Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit
Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this
schedule may differ from amounts presented in, or used in preparation of, the basic consolidated financial
statements.
De Minimis Rate Used: N
Rate Explanation: For the Research and Development Cluster, QHS did not elect to use the 10% de minimis indirect cost rate
as discussed in the Uniform Guidance Section 200.414 as QHS has a negotiated rate with the United
States Department of Health and Human Services for the year ended June 30, 2022.
During the year ended June 30, 2021, QHS was the recipient of funds under the CARES Act Provider
Relief Fund program. In accordance with guidance provided in the OMB 2 CFR 200 Part 200 Compliance
Supplement, such amounts are reflected, to the extent utilized, in the Schedule of Expenditure of Federal
Awards for the year ended June 30, 2022.
Title: (5) Restatement of Schedule of Expenditures of Federal Awards
Accounting Policies: The accompanying schedule of expenditures of federal awards includes the federal grant activity of The
Queen’s Health Systems and its subsidiaries (QHS) and is presented on the accrual basis of accounting.
The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of
Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit
Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this
schedule may differ from amounts presented in, or used in preparation of, the basic consolidated financial
statements.
De Minimis Rate Used: N
Rate Explanation: For the Research and Development Cluster, QHS did not elect to use the 10% de minimis indirect cost rate
as discussed in the Uniform Guidance Section 200.414 as QHS has a negotiated rate with the United
States Department of Health and Human Services for the year ended June 30, 2022.
The schedule of expenditures of federal awards has been restated to include additional expenditures of
$5,000,000 for the Provider Relief Fund (assistance listing number 93.498). These expenditures were
inadvertently omitted from the schedule of expenditures of federal awards.